Biotechnology New Research

November 8, 2014
The Robot That Walks On Water

Into the memorandum of understanding finalized in London on Wednesday night, Asia Construction Bank Overseas (CCBI) agreed to supply £1.5 million generate a unique technology center in a relationship between your University's Institute of Biomedical Engineering and biotechnology firm China Regenerative drug International.

The CCBI-CRMwe tech Centre will undoubtedly be section of Oxford's Institute of Biomedical Engineering and can concentrate on regenerative medication, using innovative research and building it into efficient remedies for use in clinics and hospitals.

Professor Andrew Hamilton, Vice Chancellor of the University of Oxford, said: 'This arrangement will build in the current cooperation between CRMI and University, helping speed up study in this establishing section of medical science.

'It also reinforces the effectiveness of Oxford’s gels Asia. Partnerships like this one support the worldwide interchange of ideas, boosting humanity’s knowledge, establishing our technology and enhancing everyday lives global.'

Mr Zhanghong Hu, President of China Construction Bank Overseas, said: 'CCBI’s participation can catalyse the collaborations between research and development institutions and business inside biomedical field in Asia, and speed up the translation and industrialisation of leading study achievements. We appreciate the technical power and effective expertise in regenerative medicine in CRMI and their particular established link utilizing the University of Oxford. Aided by the monetary energy of CCBI, we expect this brand new system provides many crucial systematic improvements to medical programs and gain to human society.'

Mr. Zhengkang Shao, Chief Executive of CRMI, stated: 'The cooperation with the University of Oxford not merely constructs a global study and development community for China Regenerative drug Global Limited, additionally provides instruction possibilities to systematic scientists in China. At the same time, the cooperation is a bridge for clinical exchanges between Asia therefore the UK, becoming a unique energy when it comes to development throughout real human life health.'

Professor Zhanfeng Cui, FREng, the Director regarding the Centre, said: 'the united kingdom features constantly occupied a respected place in the field of stem mobile analysis. We're constantly keen to convert the best medical study into clinical programs. The collaboration among Asia Regenerative drug Global, Asia Construction Bank Overseas additionally the University of Oxford provides good chance to combine the leading position in study and improvement the University of Oxford, the industrialisation and commercialisation platforms of CRMI, as well as the financial strength of CCBI. The outcome may benefit both British and China.'

See also:
  • term paper #TTGDWJTCWSUY8380748776
Source: www.ox.ac.uk
RELATED VIDEO
The changing face of biotechnology research at ILRI
The changing face of biotechnology research at ILRI
The RAS-RAF Pathway: New Cancer Research
The RAS-RAF Pathway: New Cancer Research
National Research Centre on Plant Biotechnology, New Delhi
National Research Centre on Plant Biotechnology, New Delhi ...
RELATED FACTS
Share this Post
Tweets